Skip to content

Esra Meidan, M.D.

NPI 1629398615ActiveIndividual· Pediatrics, Pediatric Rheumatology· Boston, MA

Pediatrics, Pediatric Rheumatology (M.D.) in Boston, Massachusetts, licensed in MA, with an NPI issued in June 2010. Part D covered 11 prescriptions written in 2024, 100% of them generic. Merck Sharp & Dohme LLC reported $1,000 in payments in 2025, mostly consulting fees.

Overview

NPI1629398615
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorYes
NPI issuedJun 2, 2010
Last updated in NPPESApr 18, 2016

Specialties and licenses

TaxonomyCodeLicenseState
Pediatrics, Pediatric Rheumatology Primary2080P0216X255053MA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Pediatric Medicine (MA)

Part D prescriptions in 2024

Prescriptions (claims)11 · 11 30-day fills
Total drug cost$101.60
Generic share100% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$1,000 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Merck Sharp & Dohme LLC$1,0001

What the 2025 payments were for

  • Consulting Fee$1,000 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Pediatrics, Pediatric Rheumatology providers in Boston

All 23 Pediatrics, Pediatric Rheumatology providers in Boston · All Pediatrics, Pediatric Rheumatology providers in Massachusetts